Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
Published on: June 14, 2024
Natural products as multi‑target therapies for sepsis‑induced myocardial dysfunction (Review)
Fei Tang1, Dong Liu2, Shi-Chao Zhu1
1Department of Pharmacy, Chongqing General Hospital, Chongqing University, Chongqing 400014, P.R. China.
Insights
Natural products offer multi-targeted strategies against sepsis-induced myocardial dysfunction (SIMD), a major cause of death. This review explores their cardioprotective mechanisms, guiding future SIMD therapies and supplements.
Area of Science:
- Cardiovascular Research
- Pharmacology
- Toxicology
Background:
- Sepsis is a leading global cause of death, with sepsis-induced myocardial dysfunction (SIMD) significantly increasing patient mortality.
- The complex pathophysiology of SIMD involves inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis, with no established effective therapies.
- Natural products have a long history in traditional medicine for cardiovascular diseases, offering potential cardioprotective benefits.
Purpose of the Study:
- To review the clinical manifestations and pathophysiology of SIMD.
- To summarize the cardioprotective mechanisms of natural products against SIMD.
- To explore structure-activity relationships and identify molecular targets for natural products in SIMD treatment.
Main Methods:
- Literature review of clinical manifestations and pathophysiology of SIMD.
- Analysis of natural products' effects on inflammation, oxidative stress, apoptosis, and mitochondrial function in SIMD.
- Exploration of structure-activity relationships and binding affinities of natural products to SIMD-related proteins.
Main Results:
- Natural products can modulate inflammatory pathways, reduce oxidative stress, inhibit apoptosis, and improve mitochondrial function in SIMD.
- Key molecular targets and binding affinities of various natural products against SIMD-related proteins were highlighted.
- Structure-activity relationship analysis provides insights into the design of effective SIMD-targeting natural compounds.
Conclusions:
- Natural products provide multi-targeted strategies for combating SIMD.
- This review offers guidance for discovering SIMD-focused dietary supplements and lead compounds.
- The findings lay the groundwork for future translational research in developing novel therapies for SIMD.
Abstract:
Sepsis, an infection‑triggered systemic inflammatory response syndrome, ranks as the third leading cause of death worldwide due to its high incidence and mortality. Sepsis‑induced myocardial dysfunction (SIMD) is a frequent and serious complication that notably increases patient morbidity and mortality. The underlying pathophysiology of SIMD involves a complex interplay of inflammation, oxidative stress, mitochondrial impairment and apoptosis, yet no effective therapies have been established. Thus, uncovering the molecular mechanisms of SIMD, identifying novel therapeutic targets and developing efficacious agents are key. For centuries, natural products have been used in traditional medical systems across China and Asia to manage cardiovascular disease. These compounds can confer cardioprotection by modulating inflammatory pathways, decreasing oxidative stress, inhibiting apoptotic cell death and improving mitochondrial function. The present review aimed to summarize the clinical manifestations and pathophysiology of SIMD and how natural products exert their protective effects. The present study aimed to explore structure‑activity relationships and highlight key molecular targets and representative natural product binding affinities for SIMD‑related proteins. In summary, the present study presents a comprehensive overview of the multi‑targeted strategies employed by natural products against SIMD and provides guidance for the discovery of SIMD‑focused dietary supplements and lead compounds, laying the groundwork for future translational research.
More Related Videos
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
What is Natural Selection?
Nature and Nurture
The Wave Nature of Light